Related Experiment Video
Updated: May 29, 2026

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
Published on: January 20, 2023
Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab
1Department of Critical Care, The Christie, Manchester, UK. cooks199@hotmail.com
Abstract:
Posterior reversible encephalopathy syndrome (PRES) is a combined clinical and radiological syndrome characterised by headaches, encephalopathy, seizures and visual loss. We present the case of a 55-year-old male who developed this condition following treatment with deoxycoformycin and alemtuzumab. We review the literature considering diagnosis, pathophysiology and optimal strategies for treatment of this condition.
Related Concept Videos
Hepatic Encephalopathy
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Encephalitis l: Introduction
Antiepileptic Drugs: Glutamate Antagonists
